Abzena appoints Dr. Moncef Slaoui to board of directors
With over 40 years of biopharma leadership experience, Dr. Slaoui will help drive innovation and growth for Abzena
With over 40 years of biopharma leadership experience, Dr. Slaoui will help drive innovation and growth for Abzena
High Throughput (HT) cloning methods have evolved into thousands of experiments being performed routinely by research labs with the aim of improving their drug development process and gain insights into complex genetic interactions. A key technology for HT cloning systems has come from Invitrogen with its simple, yet flexible Gateway® technology.
Increasing accessibility for flow cytometry applications in emerging and established markets
Asia is a range of advanced flow chemistry products from Syrris. It has been designed by chemists for chemists to enable the widest variety of chemical reactions and ultimate ease of use.
Discover how Miele Professional’s on-site testing services can help overcome the most challenging laboratory cleaning applications
New funding to advance Truvian’s clinical trials to secure FDA clearance for its blood testing platform
This month’s webinar explores digitization and context in full-field morphological hematology